Top Medical News from Across Medscape

  • First Data on Older Breast Cancer Pts on CDK4/6 InhibitorsGiving CDK4/6 inhibitors to breast cancer patients aged ≥70 years yields a similar progression-free survival to that seen in younger women, although the toxicity is more severe, say FDA researchers.
  • UK Expands Conscientious Objections in New Training GuidesNow trainees can opt out of providing more sexual and reproductive healthcare services, but only if they can ensure that patients' needs will be met by other providers. US guidelines are similar.
  • Medicare to More Closely Scrutinize Opioid PrescribingMedicare will more closely scrutinize opioid prescribing and dispensing beginning in 2019, following through on a proposal outlined in a major 2016 law aimed at addressing the opioid crisis.

Special Report

  • Changes in the US healthcare system are coming fast and furious -- and it's almost impossible to keep up.  Let us do it for you.

Business of Medicine

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California